Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial

233

Citations

12

References

2019

Year

Yuankai Shi, Hang Su, Yongping Song, Wenqi Jiang, Xiuhua Sun, Wenbin Qian, Wei Zhang, Yuhuan Gao, Zhengming Jin, Jianfeng Zhou,

The Lancet Haematology

Lymphoid NeoplasiaMedicineImmunotherapyOncologyRadiation Oncology

References

	Year	Citations

Page 1